Baxter International Inc. logo

Baxter International Inc. (BTL)

Market Closed
15 Oct, 08:00 PM
XMUN XMUN
€
22. 14
-0.12
-0.5392%
€
16.94B Market Cap
84.13 P/E Ratio
0.07% Div Yield
60 Volume
2.59 Eps
€ 22.25
Previous Close
Add Transaction
Day Range
22.14 22.14
Year Range
13.9 24.66
Want to track BTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BTL closed today lower at €22.14, a decrease of -0.5392% from yesterday's close, completing a monthly decrease of -1.2492% or -€0.28. Over the past 12 months, BTL stock gained 35.5979%.
BTL pays dividends to its shareholders, with the most recent payment made on Oct 01, 2026. The next estimated payment will be in In 2 months on Jan 01, 2027 for a total of €0.01.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.38%, based on the last three reports.
Baxter International Inc. has completed 5 stock splits, with the recent split occurring on Jul 01, 2015.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BTL Chart

Baxter International: The Vantive Transition Complicates Margin Recovery

Baxter International: The Vantive Transition Complicates Margin Recovery

Baxter International is rated Hold, with a $25 target price and limited 2.6% upside, reflecting muted near-term margin recovery. Revenue growth is supported by Advanced Surgery and compounding, but infusion solutions face structural headwinds, and Novum IQ LVP supply issues persist. Margins lag revenue growth; cost reductions and inventory normalization may help, but transition expenses and debt reduction remain priorities through 2027.

Seekingalpha | 2 days ago
Are Investors Undervaluing Baxter International (BAX) Right Now?

Are Investors Undervaluing Baxter International (BAX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 week ago
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Zacks | 1 week ago

Baxter International Inc. (BTL) FAQ

What is the stock price today?

The current price is €22.14.

On which exchange is it traded?

Baxter International Inc. is listed on XMUN.

What is its stock symbol?

The ticker symbol is BTL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.07%.

What is its market cap?

As of today, the market cap is 16.94B.

Has Baxter International Inc. ever had a stock split?

Baxter International Inc. had 5 splits and the recent split was on Jul 01, 2015.

Baxter International Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Andrew Hider CEO
XMUN Exchange
US0718131099 ISIN
US Country
37,500 Employees
28 Aug 2026 Last Dividend
1 Jul 2015 Last Split
27 Oct 1981 IPO Date

Overview

Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.

Products and Services

  • Sterile Intravenous (IV) Solutions

    These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.

  • Infusion Systems and Devices

    Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.

  • Parenteral Nutrition Therapies

    Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.

  • Generic Injectable Pharmaceuticals

    The company supplies a range of generic injectables, including essential drugs for acute care settings.

  • Surgical Hemostat and Sealant Products

    These products are utilized to control bleeding and promote healing in surgical procedures.

  • Advanced Surgical Equipment

    Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.

  • Smart Bed Systems

    These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.

  • Patient Monitoring and Diagnostic Technologies

    Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.

  • Respiratory Health Devices

    Devices designed to assist with breathing disorders and respiratory health management.

  • Dialysis Therapies and Services

    Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.

  • Adhesion Prevention Products

    These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.

  • Drug Compounding

    Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.

  • Inhaled Anesthesia

    Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.

Contact Information

Address: One Baxter Parkway
Phone: 224 948 2000